[3 H]TBOB binding with a regional heterogeneity similar to that produced by Zn 2+ . These results are consistent with Zn2+ acting at the previously detected recognition site on the GABA,, receptor complex, distinct from the picrotoxin, GABA, and benzodiazepine sites . The regional heterogeneity of the Zn 2+ effect may reflect differential regional distribution of GABAA receptor subtypes among brain regions . Other divalent canons probably act at the Zn 2+ binding site .
The GABAA receptor is the major mediator of synaptic inhibition in the CNS and structurally is a heterooligomeric protein comprised offive (or fewer) subunits per active complex (Burt and Kamatchi, 1991) . Molecular cloning studies have provided evidence for the existence of a number of different subunits forming the GABAA receptor, and each of these subunits has a distinct regional distribution in the brain (Olsen and Tobin, 1990; Burt and Kamatchi, 1991 ; Lüddens and Wisden, 1991 ; Doble and Martin, 1992; Wisden et al., 1992) . Functionally, the GABAA receptor incorporates a chloride ionophore, as well as binding sites for several classes of ligands that interact allosterically either to potentiate or to inhibit receptor function (Burt and Kamatchi, 1991 ; Sieghart, 1992) .
Divalent canons have been shown to modulate GABAA receptors in biochemical and electrophysio-logical studies . Zn2+ and other metal canons, including Cd2+, Nit+, Mn2+, and Cot+, inhibited the GABA response of neurons in a variety of preparations (Smart and Constanti, 1982; Kaneko and Tachibana, 1986; Celentano et al., 1991 ; Smart, 1992; Kilié et al., 1993) . Binding studies have provided evidence for Zn2+ modulation of GABA ligand binding . Zn2+ enhanced the specific binding of [3H] diazepam in the CNS (MacKerer and Kochman, 1978) . Although Zn2+ seemed to increase [3H]GABA binding to synaptic membranes at physiological concentrations, it inhibited the binding at pharmacotoxicological doses (Baraldi et al., 1984 ). An autoradiographic study showed that Zn2+ inhibited [3H]GABA binding to GABAB receptors, but not significantly to GABAA receptors in any brain region (Turgeon and Albin, 1992) . For the picrotoxin binding site, a binding site on the GABA,, receptor complex whose binding is modulated by the activation of other ligand binding sites of the GABAA receptor complex, there are no published data on the effect of Zn2+ and other divalent canons.
The effects of drugs on picrotoxin ligand binding have been used frequently to assess ligand interactions with the GABAA receptor complex . The purposes of this study were to elucidate Zn2+ effects on picrotoxin ligand binding, to examine the regional heterogeneity of the Zn2+ effect on GABAA receptors, and to study the possible interaction of Zn2+ effects with the effects of other classes of GABAA receptor ligands . The picrotoxin binding site of the GABAA receptor complex can be assayed with t-[3H]-butylbicycloorthobenzoate ([3H]TBOB) (Lawrence et al., 1985; O'Connor and McEwen, 1986; Sakurai et al., 1992) . We used in vitro quantitative autoradiography to determine the effects of Zn2+ on [3H]TBOB binding in rat brain .
EXPERIMENTAL PROCEDURES
Male Sprague-Dawley rats (175-199 g ; Harlan Labs, Indianapolis, IN, U .S .A .), were decapitated, and their brains rapidly removed and frozen in Lipshaw embedding matrix surrounded by powdered dry ice . Twenty-micrometer-thick sections were cut horizontally on a Lipshaw cryostat . Sections were obtained at the level including the caudoputamen, thaw-mounted onto 2 X subbed gelatin-coated slides on a warming plate, and stored at -20°C until the time of assay . All assays were performed 24 h after decapitation . Sections were run in triplicate. Slide-mounted tissue sections were warmed to room temperature and prewashed for 3 X 10 min in buffer (50 mM Tris-HCl plus 1 mM EDTA, pH 7 .4 at 4°C) at 4°C and dried under a stream of cool air . Binding of [ 3 H]TBOB (20 nM) was carried out in buffer (50 mMTris-HCl plus 120 mMNaCI, pH 7 .4, at room temperature) for 90 min at room temperature . The incubation was terminated by two 30-min rinses in buffer (50 mM Tris-HCI, pH 7 .4, at 4°C) at 4°C, followed by a brief dip in distilled water. To quantify ligand binding density, the optical density of coexposed standards was determined and a standard curve generated by fitting standard values with a fourth-degree polynomial regression equation . Standards were commercial'°C plastic standards (ARC, St . Louis, MO, U .S .A .) . Use of the standards and derived standard curve allow conversion of areal optical density to picomoles per milligram of protein . Areas read included the cortical laminae I-III, lamina IV, and laminae V-VI, hippocampal CA 1 stratum oriens, CA 1 stratum radiatum, CA3 stratum oriens, CA3 stratum radiatum, and dentate gyrus, striatum, thalamus (laterodorsal thalamic nucleus and lateral posterior thalamic nucleus), septum, superior colliculus, inferior colliculus, periaqueductal gray matter, and cerebellar molecular and granule cell layers . Ten to 20 readings per area from triplicate sections were averaged . IC SO values for Zn 2+ were calculated by log-logit analysis . In the saturation experiment, values of specific [ 3 H]TBOB bound were quantified to construct Scatchard plots . 
RESULTS

ZnZ+ modulation of [3 H]TBOB binding
ZnZ+ produced dose-dependent inhibition of [3 H]-TBOB binding in rat brain sections (Fig . 1 . Picrotoxin displaced to the same extent all the [ 3 H]TBOB bound in all brain regions (data not shown) . On the other hand, there were regional differences in Zn Z+ inhibition of [3 H]TBOB binding (Fig. 1) . ICSO values for Zn 2+ were significantly different among brain regions (p < 0 .05 on ANOVA ; Table 1), with IC SO values lowest in cortical laminae I-III, the cerebellar molecular layer, and septum . Relatively low IC so values were observed also in most subfields of the hippocampus, the striatum, and cerebellar granule cell layer . Relatively high ICSO values were found in cortical laminae V-VI, thalamus, superior colliculus, inferior colliculus, and periaqueductal gray matter .
Pharmacological profile of [ 3H]TBOB binding
Compounds that modulate the activity of the GA-BA A receptor complex allosterically modulate bind-604 A . KUME ET AL . (Lloyd et al ., 1990 ; Sakurai et al ., 1992 ; Kume et al ., unpublished observations) . GABAA agonists, such as muscimol and isoguvacine, inhibit TBPS and TBOB binding (Squires et al ., 1983 ; Lawrence et al ., 1985 ; Edgar and Schwanz, 1990 ; Sakurai et al ., 1992) , whereas the GABA A competitive antagonist bicuculline enhances their binding in the cerebellar granule cell layer (Squires et al ., 1983 ; Korpi et al ., 1992 ; Sakurai et al ., 1992) . In this experiment, Zn 2+ inhibited [3H]TBOB binding in the presence of either clonazepam or zolpidem (Fig . 3) . In the presence of either isoguvacine or bicuculline, Zn 2+ produced approximately the same percent reduction of TBOB binding as that produced in the absence of these compounds. The effects of Zn 2+ and benzodiazepines, isoguvacine, and bicuculline seemed to be essentially additive. Picrotoxin is considered to be a competitive inhibitor of [3H]TBOB (Lawrence et al ., 1985) . The inhibition by picrotoxin and Zn 2+ also seemed to be additive (Fig . 3) Our results are consistent with prior electrophysiologic data and indicate that our binding data address the same phenomena described in electrophysiologic studies. Our observed IC So values approximate 100 wM, which is consistent with results obtained in several functional studies (Smart and Constanti, 1982 ; Westbrook and Mayer, 1987 ; Celentano et al ., 1991 ; Legendre and Westbrook, 1991 ; Smart et al ., 1991 ; Smart, 1992 ; Kilié et al ., 1993) , and the effects of ZnZ+ are mimicked by other divalent metal canons, a phenomenon noted also in electrophysiologic studies Zn Z+ EFFECT ON TBOB BINDING (Kaneko and Tachibana, 1986 ; Celentano et al ., 1991) .
ZnZ+ is present in many synaptic vesicles in the vertebrate CNS (Pérez-Clausell and Danscher, 1985) and is released into the extracellular space during neuronal activity (Assaf and Chung, 1984 ; Howell et al ., 1984) . Assaf and Chung (1984) demonstrated extracellular concentrations of ZnZ+ as high as 300~M following depolarization . The effective concentration range for Zn Z+ effects in our study and prior electrophysiologic studies (Smart and Constanti, 1982 ; Westbrook and Mayer, 1987 ; Celentano et al ., 1991 ; Legendre and Westbrook, 1991 ; Smart et al ., 1991 ; Smart, 1992 ; Kilié et al ., 1993) is within the probable physiological concentration range of ZnZ+ within the synaptic cleft. ZnZ+ may function as an endogenous neuromodulator of GABA A receptor complex function within the CNS.
Our binding data provide evidence for regional differences in the Zn Z+ effect on the GABA A receptor complex. Regions showing the greatest inhibition of [3H]TBOB binding were cortical laminae I-III, most areas of hippocampus, striatum, septum, and cerebellar cortex . Regions with relatively less inhibition of [3H]TBOB binding included cortical laminae V-VI, thalamus, superior colliculus, inferior colliculus, and periaqueductal gray matter.
The pharmacological and molecular biological evidence for regional heterogeneity of the GABAA receptor complex has been widely reported, and regional/ cellular differences in the expression of GABAA receptor subtypes probably underlie, at least in part, regional/cellular differences in receptor function and pharmacology (Olsen and Tobin, 1990 ; Burt and Kamatchi, 1991) . Recent recombinant receptor studies have shown that GABA A receptors expressing the^y2 subunit are relatively insensitive to Zn Z+ (Draguhn et al ., 1990 ; Smart et al ., 1991) , suggesting that the presence of y2 subunits is an important determinant of the relative Zn Z+ sensitivity of native GABAA receptors . It is likely that each brain region expresses a variety of GABA A receptors of varying isoform composition with substantial regional differences in the expressed amount of different types of receptor heterooligomers. The 'y2 subunit is expressed in vir- tually all brain regions examined , albeit at low levels in many regions, and it is likely that most, if not all, brain regions possess y2-containing GABAA receptors . Recombinant receptors without y2 subunits [a1ß1 (Draguhn et al., 1990) , a1ß2 (Smart et al., 1991) Our autoradiographic binding data, however, suggest that the relative abundance of y2 subunits is not the sole determinant of regional differences in the Zn z+ sensitivity of GABAA receptors . The neocortex, hippocampus, and cerebellar cortex are brain regions J. Neurochem., Vol. 62, No . 2, 1994 A . KUME ET AL.
in which abundant y2 mRNA has been detected, and the 'y2 subunit is considered to be a primary component of native GABAA receptor complexes Wisden et al., 1992) . Therefore, those regions are predicted to be less sensitive to Zn z+ . In our autoradiograms, however, those brain regions showed relatively high sensitivity to the effects ofZnz+ . Moreover, our data show that thalamus, which contains a relatively low level of~y2 subunit mRNA , was relatively insensitive to Zn z+ . These results are consistent with the suggestion of Smart et al . (1991) that some combinations of GABA A receptor subunits that lack the y2 subunit are also likely to be insensitive to Znz+. Comparison of our data with the reported distribution of other GABAA receptor subunit mRNAs reveals that the distribution of no single subunit correlates with the distribution of the Znz+ effect on [ 3 H]TBOB binding . The degree of susceptibility to the effects ofZnz+ may be regulated by complex combinations ofsubunits and/orby posttranslational modification of GABAA receptor complexes.
Electrophysiologic studies (Smart and Constanti, 1982 ; Celentano et al., 1991 ; Smart, l 992) indicate that modulation of GABA A receptor function by benzodiazepines, barbiturates, neurosteroids, bicuculline, and picrotoxin does not interfere with the antagonism exerted by Znz+. These studies suggest the existence of a Znz+ site distinct from other modulatorv GABAA ligand binding sites . Our binding data are consistent with this inference . The effect of Zn z+ and those of other GABAA ligands on [ 3H]TBOB binding seemed to be additive, a result consistent with the existence of a separate Zn z+ site. There is a possible discrepancy between our results and prior electrophysiologic data (Celentano et al., 1991 ; Smart, 1992) . Our results indicate that Znz+ inhibits picrotoxin ligand binding, and this suggests that Znz+ might decrease the effectiveness ofpicrotoxin, a result not apparently FIG . 4 . Divalent metal cations inhibit [3H]TBOB binding with similar regional differences in effect . [3 H]TBOB binding was more inhibited in laminae I-III than in laminae IV and V-VI of the cerebral cortex . Data are means ± SEM (bars) from experiments done with three animals . 'A significant difference from laminae I-III and IV was noted using ANOVA (P < 0 .05) .
seen in prior studies . Zn2+, however, is a noncompetitive inhibitor of [3H]TBOB binding with a predominant effect on Bmax and little effect on binding site affinity. Prior studies of Zn2+-picrotoxin interactions were done with single, subsaturating concentrations of picrotoxin, and full dose-response curves achieving saturating concentrations of picrotoxin might be necessary to document a Zn2+-picrotoxin interactÍOn.
In addition to Zn2+, other divalent metal canons, such as Cot+, Ni2+, Mn2+, and Cd2+, also have been reported to inhibit GABA-induced current noncompetitively (Kaneko and Tachibana, 1986; Celentano et al., 1991) . These canons probably act at a common site, but possess different intrinsic efficacies as allosteric inhibitors, such that Zn2+ has greater efficacy than Cd2+ (Celentano et al., 1991) . In the present study, 300~M Ni2+, Cd2 , and Cue+ inhibited [3H]-TBOB binding as well as 300~M Zn2+. Moreover, there were regional differences in the inhibition of ['H]TBOB binding, similar to that produced by Zn2+ . These results suggest that Ni2+, Cd2+, and Cue+ act at the Zn2+ binding site .
Further studies will be necessary to establish the subunit composition, location, and functional properties of cation-sensitive GABAA receptor subtypes .
